Article info
PDFGut microbiota
Original research
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
- Correspondence to Professor Max Nieuwdorp, Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, Noord-Holland, Netherlands; m.nieuwdorp{at}amsterdamumc.nl
Citation
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Publication history
- Received July 29, 2020
- Revised September 29, 2020
- Accepted September 30, 2020
- First published October 26, 2020.
Online issue publication
February 19, 2021
Article Versions
- Previous version (19 February 2021).
- Previous version (19 February 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.